SMMT
Summit Therapeutics Inc. NASDAQ Listed Mar 5, 2015$17.14
Mkt Cap $13.3B
52w Low $13.83
19.3% of range
52w High $30.98
50d MA $18.45
200d MA $19.57
P/E (TTM)
-11.2x
EV/EBITDA
-16.1x
P/B
18.3x
Debt/Equity
0.0x
ROE
-163.9%
P/FCF
-40.4x
RSI (14)
—
ATR (14)
—
Beta
-1.37
50d MA
$18.45
200d MA
$19.57
Avg Volume
2.9M
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.
One Broadway · Cambridge, MA 02142 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | -0.27 | -0.24 | +10.8% | 21.46 | -25.3% | -24.9% | +5.4% | +3.3% | +1.8% | -3.9% | — |
| Feb 23, 2026 | AMC | -0.10 | -0.29 | -182.6% | 16.09 | -1.9% | +0.2% | -2.7% | +0.8% | +5.0% | -2.4% | — |
| Oct 20, 2025 | AMC | -0.18 | -0.31 | -76.3% | 20.04 | -0.2% | -6.5% | +2.2% | -2.1% | +2.8% | +0.9% | — |
| Aug 11, 2025 | AMC | -0.09 | -0.76 | -736.9% | 28.25 | -4.2% | -9.1% | +4.6% | -1.6% | +0.9% | -1.5% | — |
| May 1, 2025 | AMC | -0.09 | -0.09 | +3.2% | 24.67 | +5.1% | +13.1% | +0.4% | -13.6% | +0.4% | +1.5% | — |
| Feb 24, 2025 | AMC | -0.08 | -0.08 | +2.2% | 18.84 | +1.9% | -3.9% | +1.0% | +1.0% | +11.9% | -7.5% | — |
| Oct 30, 2024 | AMC | -0.07 | -0.08 | -14.3% | 18.65 | +0.5% | -0.3% | +2.2% | +5.1% | +2.2% | +2.5% | — |
| Aug 6, 2024 | AMC | -0.06 | -0.05 | +16.7% | 9.54 | -0.4% | -1.5% | +8.9% | +5.3% | +1.9% | +2.5% | — |
| May 1, 2024 | AMC | -0.06 | -0.06 | +0.0% | 4.70 | -0.4% | -13.6% | +8.1% | +1.8% | +18.8% | -6.6% | — |
| Feb 20, 2024 | AMC | — | -0.04 | — | 3.74 | +0.0% | +9.9% | +4.6% | +7.9% | -3.9% | -1.3% | — |
| Nov 7, 2023 | AMC | — | -0.03 | — | 1.92 | -0.3% | -4.7% | -3.8% | +8.5% | -3.4% | +7.1% | — |
| Aug 9, 2023 | AMC | — | -0.02 | — | 1.94 | +0.5% | -8.2% | -3.4% | +15.1% | -3.0% | -7.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Piper Sandler | Maintains | Neutral → Neutral | — | $21.46 | $16.02 | -25.3% | -24.9% | +5.4% | +3.3% | +1.8% | -3.9% |
| Apr 8 | Stifel | Maintains | Buy → Buy | — | $19.22 | $19.99 | +4.0% | -2.1% | +2.7% | +1.9% | +1.8% | +4.1% |
| Mar 16 | Jefferies | Downgrade | Buy → Hold | — | $16.12 | $16.07 | -0.3% | +0.4% | -2.0% | -1.6% | +0.8% | -1.3% |
| Feb 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.09 | $15.78 | -1.9% | +0.2% | -2.7% | +0.8% | +5.0% | -2.4% |
| Feb 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.48 | $14.21 | -1.9% | -2.9% | +3.8% | -1.2% | -4.0% | +8.2% |
| Jan 30 | Citizens | Maintains | Market Outperform → Market Outperform | — | $15.40 | $15.20 | -1.3% | -6.0% | -2.9% | +3.8% | -1.2% | -4.0% |
| Dec 17 | Barclays | Upgrade | Underweight → Equal Weight | — | $17.23 | $17.65 | +2.4% | -1.3% | +0.2% | +4.6% | +1.9% | -0.2% |
| Oct 22 | Guggenheim | Maintains | Buy → Buy | — | $18.74 | $19.58 | +4.5% | +2.2% | -2.1% | +2.8% | +0.9% | -1.2% |
| Oct 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $20.04 | $19.99 | -0.2% | -6.5% | +2.2% | -2.1% | +2.8% | +0.9% |
| Oct 21 | Barclays | Maintains | Underweight → Underweight | — | $20.04 | $19.99 | -0.2% | -6.5% | +2.2% | -2.1% | +2.8% | +0.9% |
| Oct 20 | Citigroup | Maintains | Buy → Buy | — | $20.99 | $18.85 | -10.2% | -4.5% | -6.5% | +2.2% | -2.1% | +2.8% |
| Oct 20 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $20.99 | $18.85 | -10.2% | -4.5% | -6.5% | +2.2% | -2.1% | +2.8% |
| Sep 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $18.94 | $18.99 | +0.3% | -4.3% | -0.2% | +6.3% | -1.8% | +1.1% |
| Sep 8 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $25.98 | $21.53 | -17.1% | -25.1% | -3.2% | -6.5% | +5.6% | +1.8% |
| Sep 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $25.98 | $21.53 | -17.1% | -25.1% | -3.2% | -6.5% | +5.6% | +1.8% |
| Sep 3 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $23.84 | $23.82 | -0.1% | -1.3% | +1.2% | +9.2% | -25.1% | -3.2% |
| Sep 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $23.70 | $23.13 | -2.4% | +0.6% | -1.3% | +1.2% | +9.2% | -25.1% |
| Aug 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $26.98 | $26.23 | -2.8% | -8.0% | -1.6% | -2.9% | +0.6% | -1.3% |
| Aug 19 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $26.29 | $25.63 | -2.5% | -3.6% | +2.1% | +0.5% | +0.7% | +0.3% |
| Aug 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $26.45 | $26.49 | +0.2% | +0.9% | -1.5% | -3.6% | +2.1% | +0.5% |
| Aug 12 | Evercore ISI | Maintains | Outperform → Outperform | — | $28.25 | $27.06 | -4.2% | -9.1% | +4.6% | -1.6% | +0.9% | -1.5% |
| Jul 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $21.28 | $21.28 | +0.0% | -0.4% | +6.7% | +8.5% | -7.9% | +1.7% |
| Jun 2 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $18.22 | $18.81 | +3.2% | -2.7% | +16.3% | -5.1% | +0.9% | +4.4% |
| May 2 | Goldman Sachs | Maintains | Buy → Buy | — | $24.67 | $25.93 | +5.1% | +13.1% | +0.4% | -13.6% | +0.4% | +1.5% |
| Apr 28 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $23.47 | $24.38 | +3.9% | +2.7% | -2.0% | +2.1% | +2.3% | +13.1% |
| Apr 25 | Jefferies | Maintains | Buy → Buy | — | $36.70 | $34.48 | -6.0% | -36.0% | +2.7% | -2.0% | +2.1% | +2.3% |
| Apr 23 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $27.35 | $29.95 | +9.5% | +21.5% | +10.4% | -36.0% | +2.7% | -2.0% |
| Mar 26 | Citigroup | Upgrade | Neutral → Buy | — | $20.24 | $21.45 | +6.0% | -1.7% | +3.6% | -1.4% | -5.1% | -2.5% |
| Feb 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $18.84 | $19.20 | +1.9% | -3.9% | +1.0% | +1.0% | +11.9% | -7.5% |
| Feb 25 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $18.84 | $19.20 | +1.9% | -3.9% | +1.0% | +1.0% | +11.9% | -7.5% |
| Jan 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $19.03 | $19.25 | +1.2% | +16.1% | +6.4% | +4.8% | -3.6% | -1.0% |
| Nov 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $18.31 | $18.36 | +0.3% | +3.7% | +5.4% | -6.9% | -1.1% | +3.1% |
| Oct 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $18.65 | $18.75 | +0.5% | -0.3% | +2.2% | +5.1% | +2.2% | +2.5% |
| Aug 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.31 | $12.40 | +0.7% | +8.4% | +1.3% | -3.3% | +1.3% | +1.7% |
| Aug 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.12 | $11.45 | +3.0% | +6.7% | -2.3% | +5.6% | +0.5% | +8.4% |
| Aug 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.25 | $11.57 | +2.8% | -1.2% | +6.7% | -2.3% | +5.6% | +0.5% |
| Jun 3 | Stifel | Maintains | Buy → Buy | — | $8.69 | $9.84 | +13.2% | +1.7% | -17.3% | +10.0% | +1.1% | -5.0% |
| May 31 | Citigroup | Maintains | Buy → Buy | — | $10.92 | $9.07 | -16.9% | -20.4% | +1.7% | -17.3% | +10.0% | +1.1% |
| Nov 25 | Oppenheimer | Maintains | Outperform → Outperform | — | $4.21 | $4.20 | -0.2% | +1.7% | +1.4% | +3.7% | +6.4% | -1.7% |
| Nov 25 | SunTrust Robinson Humphrey | Downgrade | Buy → Hold | — | $4.21 | $4.20 | -0.2% | +1.7% | +1.4% | +3.7% | +6.4% | -1.7% |
| Nov 25 | Janney Capital | Downgrade | Buy → Neutral | — | $4.21 | $4.20 | -0.2% | +1.7% | +1.4% | +3.7% | +6.4% | -1.7% |
| Nov 25 | H.C. Wainwright | Maintains | Buy → Buy | — | $4.21 | $4.20 | -0.2% | +1.7% | +1.4% | +3.7% | +6.4% | -1.7% |
| Nov 18 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $4.58 | $4.32 | -5.7% | -1.3% | +0.2% | -2.9% | +0.0% | -4.3% |
| Mar 19 | H.C. Wainwright | Maintains | Buy → Buy | — | $2.75 | $2.71 | -1.5% | -2.9% | -12.4% | -12.0% | +2.9% | +11.8% |
| Mar 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.75 | $2.71 | -1.5% | -2.9% | -12.4% | -12.0% | +2.9% | +11.8% |
| Jun 28 | Janney Capital | Downgrade | Buy → Neutral | — | $2.55 | $2.52 | -1.2% | -6.7% | +2.9% | +1.2% | +4.8% | -5.0% |
| Jun 28 | Janney Montgomery Scott | Downgrade | Buy → Neutral | — | $2.55 | $2.52 | -1.2% | -6.7% | +2.9% | +1.2% | +4.8% | -5.0% |
| Jun 27 | SunTrust Robinson Humphrey | Downgrade | Buy → Hold | — | $12.65 | $2.90 | -77.1% | -79.8% | -6.7% | +2.9% | +1.2% | +4.8% |
| May 2 | Janney Capital | Maintains | Buy → Buy | — | $13.42 | $13.50 | +0.6% | +2.5% | -0.1% | -0.1% | +0.2% | -0.1% |
| Feb 13 | BTIG Research | Maintains | Buy → Buy | — | $10.80 | $11.06 | +2.4% | +6.7% | +4.6% | +1.1% | -4.1% | -2.2% |
No insider trades available.
Data updated apr 27, 2026 1:56am
· Source: massive.com